Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Healthcare stocks outperform
Mon, 15 Oct 11:30 am

Indian equity markets continued to trade in the red after a weak opening earlier in the morning. Sectoral indices traded mostly in the red except healthcare, realty and energy stocks.

The BSE-Sensex is trading lower by 50 points and NSE-Nifty is trading lower by 20 points. BSE Mid Cap is trading flat and BSE Small Cap is trading higher by 0.5%. The rupee is trading at 53.09 to the US dollar.

Media stocks are trading mixed. Network 18 Media and Broadcast Initiatives are the top gainers while Compact Disc and Deccan Chronicle are losing the maximum. Print media company HT Media declared results for 2QFY13. The company reported 4.5% YoY growth in net sales over the same quarter last year. Tough economic environment resulted in a fall in advertising revenue by 1% YoY. Subscriptions grew by 11% YoY. A jump of 22% YoY growth was witnessed in employee expenses. Higher operating expenditure growth of 8.5% YoY during the quarter resulted in operating profits falling by 19.5% YoY. Interest expenses were up by 9% YoY during the quarter ended September 2012. HT Media,s net profits were down by 24% YoY and the net profit margins shrank by 3.5%.

Energy stocks are trading in the green led by Essar Oil and Gujarat State Petronet Ltd (GSPL). According to a leading financial daily, Oil and Natural Gas Corporation (ONGC) has been invited by Russia to buy a stake in the Magadan-2 field operated by Rosneft in the northern part of the Sea of Okhotsk. The proposal was made to the Indian oil ministry officials at the India Russia Joint Working Group meeting. ONGC has confirmed that they were viewing the data related to the field. This comes at a time when the Indian Government has told state firms to secure energy assets overseas as the country's own output is not sufficient to meet the demand of the Indian economy. Russia granted exploration licenses for five areas in the Sea of Okhotsk - Magadan-1, 2 and 3, Lisyansky and Kashevarovsky to Rosneft without bidding at the end of last year. Recoverable resources in the area are estimated at 2.8 bn tonnes of oil equivalent.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Healthcare stocks outperform". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Agora Research Private Limited.

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Agora Research Private Limited (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.